Last edition
News about "NeuroRestore ACD856 "
AlzeCure Gets EU Grant for Phase 2 Clinical Trial of NeuroRestore ACD856
This funding will support AlzeCure’s planned Phase IIa study of NeuroRestore ACD856 in Alzheimer’s patients.
NeuroRestore ACD856 | 19/02/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members